References
- Fuchs A, Gotta V, Decker M-L, Szinnai G, Baumann P, Bonhoeffer J., Ritzet N., Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial. Clin Microbiol Infect 2018; 24: 1341.e1–1341.e7 doi:10.1016/j.cmi.2018.03.016
- Ciuca IM, Pop L, Horhat F.G., Rogobete AF, Role of biomarkers in cystic fibrosis pulmonary disease, Pediatru.ro 2017; 46(2): 8–10 doi: 10.26416/Pedi.46.2.2017.806
- Wallace, R. G., Twomey, L. C., Custaud, M. A., Moyna, N., Cummins, P. M., Mangone, M., & Murphy, R. P. (2016). Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment. BioMed Research International, 2016, [2465763]. https://doi.org/10.1155/2016/2465763
- Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 2007; 4(4):406–417. doi:10.1513/pats.200703-044BR
- Bedreag OH, Sandesc D, Chiriac SD, Rogobete AF, Cradigati AC, Sarandan M, Papurica M et al. The Use of Circulating miR-NAs as Biomarkers for Oxidative Stress in Critically Ill Poly-trauma Patients. Clinical Laboratory. 2016; 62(3):263–274. DOI: 10.7754/clin.lab.2015.150740.
- Dumache R, Rogobete AF, Bedreag OH, Sarandan M, Cradigati AC , Papurica M, Corina Dumbuleu M, et al. Use of miR-NAs as biomarkers in sepsis. Anal Cell Pathol (Amst) 2015; 2015:186716. doi:10.1155/2015/186716
- Quon BS, Ngan DA, Wilcox PG, Man SFP, Sin DD (2014) Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis. PLOS ONE 9(2): e89341. https://doi.org/10.1371/journal.pone.0089341
- Ranganathan SC, Hall GL, Sly PD, Stick SM, Douglas TA; Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It? Am J Respir Crit Care Med 2017; 195(12):1567–1575. doi:10.1164/rccm.201606-1107CI
- Decraene A, Willems-Widyastuti A, Kasran A, De Boeck K, Bullens DM, Dupont LJ. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respir Res 2010; 11(1): 177. doi:10.1186/1465-9921-11-177 2010, 11:177
- Rao JR, Nelson D, Moore JE, Millar BC, Goldsmith CE, Rendall J, Elborn JS. Non-coding small (micro) RNAs of Pseudomonas aeruginosa isolated from clinical isolates from adult patients with cystic fibrosis. Br J Biomed Sci 2010; 67(3): 126–132 . doi:10.1 080/09674845.2010.11730309.
- Tsuchiya M, Kumar P, Bhattacharyya S, Chattoraj S, Srivastava M, Pollard HB, Biswas R. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells. J Interferon Cytokine Res 2013; 33(3): 121–129. doi:10.1089/ jir.2012.0074
- Bedreag, O. , Rogobete, A. , Dumache, R. , Sarandan, M. , Cradigati, A. , Papurica, M. , Craciunescu, M. , Sandesc, D. et al. (2015). Use of circulating microRNAs as biomarkers in critically ill polytrauma patients. Biomarkers and Genomic Medicine 2016, 7(4): 131–138 doi: 10.1016/j.bgm.2015.11.002
- Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003; 2(1): 29–34. doi:10.1016/S1569-1993(02)00141-8
- Mauch RM, Rossi CL, Ribeiro JD, Ribeiro AF, Nolasco da Silva MT, Levy CE. Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA). Diagn Pathol 2014; 9:158. doi:10.1186/s13000-014-0158-z
- da Silva Filho LV, Tateno AF, Martins KM, et al. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatr Pulmonol 2007; 42(10): 938–944. doi:10.1002/ppul.20686
- Grasemann H, Knauer N, Büscher R, Hübner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 2000;162(6):2172–2176. doi:10.1164/ajrccm.162.6.2003106
- Smith D, Spaněl P, Gilchrist FJ, Lenney W. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection. J Breath Res 2013;7(4):044001. doi:10.1088/1752– 7155/7/4/044001
- Enderby B, Smith D, Carroll W, Lenney W. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol 2009; 44(2): 142– 147. doi:10.1002/ppul.20963
- Gilchrist F., Belcher J., Jones A.M., Smith D., Smyth A.R., Southern K.W., Španěl P., Webb A.K., Lenney W. Exhaled breath hydrogen cyanide as a marker of early
- Pseudomonas aeruginosa infection in children with cystic fibrosis, ERJ Open Research
- 2015 1: 00044–2015; DOI: 10.1183/23120541.00044-2015
- Zhou, X., Li, X., Ye, Y. et al. MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuits. Nat Commun
- 5, 3619 (2014). https://doi.org/10.1038/ncomms4619
- Dai, L. L., Gao, J. X., Zou, C. G., Ma, Y. C., Zhang, K. Q. Mir-233 modulates the unfolded protein response in C. elegans during Pseudomonas aeruginosa infection. PLoS Pathog 2015 11:e1004606. doi: 10.1371/journal.ppat.1004606